Skin Inflammation and PK of Azithromycin

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 1, 2026

Study Completion Date

July 1, 2026

Conditions

Skin Infection

Interventions

DRUG

Azithromycin

500 mg once daily for 3 days

DIAGNOSTIC_TEST

Biopsy

Skin punch biopsy

OTHER

Skin inflammation model

LPS- or imiquimod induced skin inflammation

All Listed Sponsors

lead

Medical University of Vienna

OTHER

NCT06170983 - Skin Inflammation and PK of Azithromycin | Biotech Hunter | Biotech Hunter